These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31967025)

  • 21. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.
    Shimon I; Nass D; Hadani M
    Pituitary; 2000 May; 2(4):289-94. PubMed ID: 11081151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer.
    Fountas A; Chai ST; Ayuk J; Gittoes N; Chavda S; Karavitaki N
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29623208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary surgery for the management of acromegaly.
    Laws ER; Vance ML; Thapar K
    Horm Res; 2000; 53 Suppl 3():71-5. PubMed ID: 10971109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained improvement in vision in a recurrent growth hormone secreting macroadenoma during treatment with octreotide in the absence of marked tumour shrinkage.
    Lindsay JR; Harding JA; Ellis PK; Sheridan B; Atkinson AB
    Pituitary; 2003; 6(4):209-14. PubMed ID: 15237932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone-secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog (90)Y-DOTATATE: case report.
    Waligórska-Stachura J; Gut P; Sawicka-Gutaj N; Liebert W; Gryczyńska M; Baszko-Błaszyk D; Blanco-Gangoo AR; Ruchała M
    J Neurosurg; 2016 Aug; 125(2):346-9. PubMed ID: 26636388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
    Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
    Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
    Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
    Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
    Wang YY; Waqar M; Abou-Zeid A; Kearney T; Caputo C; Davis J; Trainer P; Higham C; Roncaroli F; Gnanalingham KK
    Neuroendocrinology; 2022; 112(4):345-357. PubMed ID: 34052822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors.
    Freda PU; Reyes CM; Nuruzzaman AT; Sundeen RE; Khandji AG; Post KD
    Pituitary; 2004; 7(1):21-30. PubMed ID: 15638294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.